var data={"title":"Isosulfan blue dye: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Isosulfan blue dye: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/40223?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=isosulfan-blue-dye-patient-drug-information\" class=\"drug drug_patient\">see &quot;Isosulfan blue dye: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577187\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Contrast Agent</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577217\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Lymphatic vessel delineation:</b> SubQ: Inject 0.5 mL into 3 interdigital spaces of each extremity per study; maximum dose: 3 mL (30 mg) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16160052\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16160053\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577222\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Subcutaneous: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (5 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Subcutaneous [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (5 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5598929\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577218\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">SubQ: Single patient use only. Due to precipitation, do not mix with local anesthetics (eg, lidocaine) in same syringe. Monitor closely for hypersensitivity for at least 60 minutes following administration.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577188\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Lymphatic vessel delineation:</b> Adjunct to lymphography to delineate lymphatic vessels in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities for visualization of the lymphatic system draining the region of injection.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577197\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Pruritus (2%; affecting abdomen, hands, and neck)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hypersensitivity: Hypersensitivity reaction (2%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Local: Local swelling (2%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&lt;1%, postmarketing, and/or case reports: Anaphylaxis; skin discoloration (including blue urticaria)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577193\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Known hypersensitivity to isosulfan, triphenylmethane (or related compounds), or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577194\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse events:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Discoloration: May cause blue discoloration of urine for 24 hours following administration. May also result in tattoo-like blue coloration of the skin at the injection site (transient or long term).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity reactions: Hypersensitivity reactions, including life-threatening anaphylactic reactions (respiratory distress, shock, angioedema), have occurred. Monitor patients closely for at least 60 minutes following administration. Patients with a history of bronchial asthma, allergies, drug reactions, or prior reactions to triphenylmethane dyes are at higher risk for reactions. Competent personnel should be available to administer emergency care (including resuscitation).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Methemoglobin: Methemoglobin levels via arterial blood gases (ABG) may be falsely elevated; co-oximetry may be required to accurately assess methemoglobin levels.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Oxygen saturation: Peripheral oxygenation measurements by pulsoximetry may be falsely depressed (peak interference 30 minutes after administration; minimal effect by 4 hours postdose); direct determination of ABG may be required.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299549\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577202\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9039&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577189\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577190\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Isosulfan blue 1% injection should be given to a pregnant woman only if clearly needed.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20681245\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if isosulfan blue is excreted in breast milk. The manufacturer recommends that caution be exercised when administering isosulfan blue to nursing women.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F45759709\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Monitor for hypersensitivity reactions for at least 60 minutes following administration. Due to interference with pulse oximetry, monitor arterial blood gases for at least 30 to 240 minutes following administration if need to evaluate oxygenation.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577209\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Following subcutaneous administration, isosulfan blue binds to serum proteins and then drained by the regional lymphatic system; blue coloration imparted by the dye permits delineation of the vessels against the surrounding tissue.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5577211\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine (up to 10%; as unchanged drug within 24 hours of administration) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16324129\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Isosulfan Blue Subcutaneous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (5 mL): $1,061.31</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Baker MG, Cronin JA, Borish L, Lawrence MG. Evaluation of a skin testing protocol for diagnosing perioperative anaphylaxis due to isosulfan blue allergy.<i> Ann Allergy Asthma Immunol</i>. 2014;113(3):330-331.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/isosulfan-blue-dye-drug-information/abstract-text/25091718/pubmed\" target=\"_blank\" id=\"25091718\">25091718</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Isosulfan blue [prescribing information]. Rockford, IL: Mylan Institutional; December 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ortiz D, Alvikas J, Riker AI. A case of severe anaphylactic reaction secondary to isosulfan blue dye injection. <i>Ochsner J</i>. 2015; 15(2):183-186.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Reed H, Shaw C, Rice M, Le HT. Isosulfan blue dye anaphylaxis presenting as impaired ability to ventilate via a laryngeal mask airway. <i>A A Case Rep</i>. 2014;3(1):1-2.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/isosulfan-blue-dye-drug-information/abstract-text/25612264 /pubmed\" target=\"_blank\" id=\"25612264 \">25612264 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sadiq TS, Burns WW, Taber DJ et al, &ldquo;Blue Urticaria: A Previously Unreported Adverse Event Associated With Isosulfan Blue,&rdquo;<i> Arch Surg</i>, 2001, 136(12): 1433-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/isosulfan-blue-dye-drug-information/abstract-text/11735875/pubmed\" target=\"_blank\" id=\"11735875\">11735875</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sprung J, Tully MJ, and Ziser A, &ldquo;Anaphylactic Reactions to Isosulfan Blue Dye During Sentinel Node Lymphadenectomy for Breast Cancer,&rdquo; <i>Anesth Analg</i>, 2003, 96(4):1051-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/isosulfan-blue-dye-drug-information/abstract-text/12651658/pubmed\" target=\"_blank\" id=\"12651658\">12651658</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9039 Version 78.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F5577187\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F5577217\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F16160052\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F16160053\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F5577222\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F5598929\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F5577218\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F5577188\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F5577197\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F5577193\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F5577194\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299549\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F5577202\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F5577189\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F5577190\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F20681245\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F45759709\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F5577209\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F5577211\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16324129\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9039|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=isosulfan-blue-dye-patient-drug-information\" class=\"drug drug_patient\">Isosulfan blue dye: Patient drug information</a></li></ul></div></div>","javascript":null}